Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15984 | 612 | 41.4 | 73% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | MODAFINIL | Author keyword | 260 | 58% | 50% | 303 |
| 2 | ARMODAFINIL | Author keyword | 18 | 47% | 5% | 28 |
| 3 | INTEGRIS SLEEP DISORDERS OKLAHOMA | Address | 12 | 86% | 1% | 6 |
| 4 | L LAFON | Address | 12 | 86% | 1% | 6 |
| 5 | ADRAFINIL | Author keyword | 10 | 73% | 1% | 8 |
| 6 | WAKE PROMOTING AGENT | Author keyword | 8 | 100% | 1% | 5 |
| 7 | WAKE PROMOTING AGENTS | Author keyword | 6 | 100% | 1% | 4 |
| 8 | MODAFINIL SULFONE | Author keyword | 3 | 100% | 0% | 3 |
| 9 | PROVIGIL | Author keyword | 3 | 100% | 0% | 3 |
| 10 | DIAG THER Y | Address | 3 | 45% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | MODAFINIL | 260 | 58% | 50% | 303 | Search MODAFINIL | Search MODAFINIL |
| 2 | ARMODAFINIL | 18 | 47% | 5% | 28 | Search ARMODAFINIL | Search ARMODAFINIL |
| 3 | ADRAFINIL | 10 | 73% | 1% | 8 | Search ADRAFINIL | Search ADRAFINIL |
| 4 | WAKE PROMOTING AGENT | 8 | 100% | 1% | 5 | Search WAKE+PROMOTING+AGENT | Search WAKE+PROMOTING+AGENT |
| 5 | WAKE PROMOTING AGENTS | 6 | 100% | 1% | 4 | Search WAKE+PROMOTING+AGENTS | Search WAKE+PROMOTING+AGENTS |
| 6 | MODAFINIL SULFONE | 3 | 100% | 0% | 3 | Search MODAFINIL+SULFONE | Search MODAFINIL+SULFONE |
| 7 | PROVIGIL | 3 | 100% | 0% | 3 | Search PROVIGIL | Search PROVIGIL |
| 8 | MPTP TREATMENT | 2 | 67% | 0% | 2 | Search MPTP+TREATMENT | Search MPTP+TREATMENT |
| 9 | POLYSACCHARIDES STATIONARY PHASES | 2 | 67% | 0% | 2 | Search POLYSACCHARIDES+STATIONARY+PHASES | Search POLYSACCHARIDES+STATIONARY+PHASES |
| 10 | SUSTAINED OPERATIONS | 2 | 30% | 1% | 6 | Search SUSTAINED+OPERATIONS | Search SUSTAINED+OPERATIONS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INDUCED WAKEFULNESS | 114 | 73% | 14% | 88 |
| 2 | PROMOTING DRUG MODAFINIL | 67 | 78% | 7% | 45 |
| 3 | AMINOBUTYRIC ACID OUTFLOW | 50 | 86% | 4% | 25 |
| 4 | AWAKENING PROPERTIES | 41 | 100% | 2% | 15 |
| 5 | SUSTAINED MENTAL WORK | 31 | 76% | 4% | 22 |
| 6 | MODAFINIL TABLETS | 27 | 92% | 2% | 11 |
| 7 | DRUG MODAFINIL | 27 | 83% | 2% | 15 |
| 8 | ADRENERGIC AGONIST MODAFINIL | 23 | 86% | 2% | 12 |
| 9 | PROMOTING AGENT MODAFINIL | 17 | 72% | 2% | 13 |
| 10 | ANTINARCOLEPTIC DRUG | 17 | 100% | 1% | 8 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Modafinil: A review of neurochemical actions and effects on cognition | 2008 | 245 | 194 | 60% |
| Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain | 2013 | 21 | 112 | 73% |
| A systematic review of modafinil: Potential clinical uses and mechanisms of action | 2006 | 159 | 102 | 61% |
| Clinical pharmacokinetic profile of modafinil | 2003 | 117 | 33 | 94% |
| Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation | 2014 | 15 | 206 | 27% |
| Approved and investigational uses of modafinil - An evidence-based review | 2008 | 70 | 136 | 65% |
| The Vigilance Promoting Drug Modafinil Modulates Serotonin Transmission in the Rat Prefrontal Cortex and Dorsal Raphe Nucleus. Possible Relevance for Its Postulated Antidepressant Activity | 2013 | 6 | 88 | 72% |
| The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders | 2013 | 10 | 178 | 48% |
| Pharmacokinetic Profile of Armodafinil in Healthy Subjects Pooled Analysis of Data from Three Randomized Studies | 2009 | 15 | 10 | 90% |
| Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial | 2008 | 17 | 12 | 75% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INTEGRIS SLEEP DISORDERS OKLAHOMA | 12 | 86% | 1.0% | 6 |
| 2 | L LAFON | 12 | 86% | 1.0% | 6 |
| 3 | DIAG THER Y | 3 | 45% | 0.8% | 5 |
| 4 | DRUG SAFETY DISPOSIT | 3 | 24% | 1.8% | 11 |
| 5 | BIOL VIEILLISSEMENT | 1 | 50% | 0.3% | 2 |
| 6 | CINCINNATI REG SLEEP | 1 | 100% | 0.3% | 2 |
| 7 | SLEEP DISORDERS OKLAHOMA | 1 | 100% | 0.3% | 2 |
| 8 | CLIN TRASTORNOS SUENO | 1 | 27% | 0.5% | 3 |
| 9 | MOL COGNIT | 1 | 21% | 0.5% | 3 |
| 10 | BASIC PHARM | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000209495 | NARCOLEPSY//CATAPLEXY//IDIOPATHIC HYPERSOMNIA |
| 2 | 0.0000173362 | ACCELERATED RESPONSE//BODILY SENSATION//CARE TEAM |
| 3 | 0.0000135271 | PRESCRIPTION STIMULANTS//NONMEDICAL USE//MORAL ENHANCEMENT |
| 4 | 0.0000094565 | SLEEPINESS//SLEEP INERTIA//SLEEP DEPRIVATION |
| 5 | 0.0000053131 | METHAMPHETAMINE//MOL NEUROPSYCHIAT SECT//MOL NEUROPSYCHIAT BRANCH |
| 6 | 0.0000048121 | 5 CHOICE SERIAL REACTION TIME TASK//5 CSRTT//REVERSAL LEARNING |
| 7 | 0.0000043306 | CONTINUOUS POSITIVE AIRWAY PRESSURE//CPAP//OBSTRUCTIVE SLEEP APNEA |
| 8 | 0.0000042097 | SLEEP HOMEOSTASIS//EEG DELTA POWER//VENTROLATERAL PREOPTIC AREA |
| 9 | 0.0000042017 | PSYCHOBIOL SECT//BENZTROPINE ANALOGS//GBR 12909 |
| 10 | 0.0000041124 | RITALIN//METHYLPHENIDATE//METHYLPHENIDATE RITALIN |